People news

Share this article:
MANUFACTURERS
UCB
has appointed Mark McDade, executive vice president, global operations. He succeeds Bill Robinson, who will retire December 31, 2008.

Somnus Therapeutics, a private specialty pharmaceutical company focused on insomnia treatments, has announced the initial four members of its board of directors: Gary Cupit, CEO; Linda Hogan, chief business officer; David Ramsay, partner, Care Capital; and Jack Britts, president and CEO, Merz Pharmaceuticals.

AGENCIES
Media buying agency Compas has promoted Nicole Woodland-DeVan, formerly executive director, promotional purchasing, to vice president, beyond branding.
Share this article:
You must be a registered member of MMM to post a comment.

Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.